Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Novel insights into early Alzheimer's disease: quantitative gradient recalled echo MRI reveals preatrophic neuronal and myelin injury concurrent with emerging amyloid pathology.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Factors influencing accelerated progression in behavioral variant frontotemporal dementia.

Journal of neurology·2026
Same author

Antisense oligonucleotide-mediated knockdown therapy in two infants with severe KCNT1 epileptic encephalopathy.

Nature medicine·2026
Same author

OpenScientist: evaluating an open agentic AI co-scientist to accelerate biomedical discovery.

medRxiv : the preprint server for health sciences·2026
Same author

Naturalistic Driving Outcomes and Sensorimotor Function in Cognitively Normal Older Adults.

Journal of the American Geriatrics Society·2026
Same author

Efficacy and Outcomes of Laser Treatments for Steatocystoma Multiplex: A Systematic Review.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026
Same journal

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Human brain connectome profiles mediate the relationship between pathology burden and clinical phenotypes in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Kat5 cKO mouse replicates biological domain signatures associated with Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Associations of self-reported obstructive sleep apnea with cognition and dementia risk in cognitively unimpaired middle-aged adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Melody Li1,2, Lisa Soke2,3, Nupur Ghoshal3

  • 1Washington University School of Medicine in St. Louis, St. Louis, MO, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
PubMed
概括
此摘要是机器生成的。

在SUNBIRD研究中,正在评估血液生物标志物,以在初级保健中诊断阿尔茨海默病 (AD). 这项研究旨在通过评估生物标志物的有效性和临床实用性来改善早期检测和治疗.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经学 神经学
  • 生物标志物研究 生物标志物研究
  • 临床诊断 临床诊断 临床诊断

背景情况:

  • 早期阿尔茨海默病 (AD) 诊断对于启动抗粉样蛋白疗法至关重要.
  • 诊断AD的血液测试是可用的,但缺乏初级保健机构的测试.
  • 生物标志物的最佳使用 (粉样β,酸,MTBR-tau) 和影响因素需要进一步调查.

研究的目的:

  • 评估血液生物标志物对阿尔茨海默病诊断和初级保健治疗的影响.
  • 用血液生物标志物评估临床和认知衰退的预测.
  • 了解伴随性疾病,种族,性别和教育对生物标志物的效用的影响.

主要方法:

  • 了解痴呆症研究中的新生物标志物研究 (SUNBIRD) 纵向跟踪约2000名参与者.
  • 参与者从不同的社区 (SEABIRD) 和初级保健/神经病诊所队列中招募.
  • 方法包括研究血液采集 (粉样蛋白,,神经丝),认知评估,调查和EHR数据提取.

主要成果:

  • 研究入学进展良好,参与者对接受研究的反是积极的.
  • 目前正在审查SEABIRD和SUNBIRD研究的设计,实施和招生情况.
  • 将介绍临床测试和转诊的结果.

结论:

  • 在AD诊断中,初级保健提供者 (PCP) 和神经病学家的现实世界注册和参与是可行的.
  • 需要进一步的研究来证实AD诊断和治疗的血液生物标志物的有效性和临床实用性.